Treatment of myasthenia gravis with methylprednisolone pulse: A double blind study

Acta Neurologica Scandinavica

Volumn 97, Issue 6, 1998, Pages 370-373

  Lindberg, C ^a,c   Andersen, O ^a   Lefvert, A K ^b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Corticosteroid; Myasthenia gravis; Treatment

Indexed keywords

AZATHIOPRINE; CHOLINERGIC RECEPTOR ANTIBODY; CHOLINESTERASE INHIBITOR; METHYLPREDNISOLONE; PLACEBO;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MUSCLE FATIGUE; MUSCLE FUNCTION; MYASTHENIA GRAVIS; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0031859010     PISSN: 00016314     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0404.1998.tb05968.x     Document Type: Article

References (25)

1. LEFVERT AK, BERGSTRÖM K, MATELL G, OSTERMAN PO, PIRSKANEN R. Determination of acetylcholine receptor antibody in myasthenia gravis: clinical usefulness and pathogenetic implications. J Neurol Neurosurg Psych 1978: 41: 394-403.
2. STANLEY EF, DRACHMAN DB. Effect of myasthenic immunoglobulinon acetylcholine receptors of intact mammalian neuromuscular junctions. Science 1978: 200: 1285-7.
3. BRUNNER NG, NAMBA T, GROB D. Corticosteroids in management of severe, generalized myasthenia gravis. Effectiveness and comparison with corticotropin therapy. Neurology 1972: 22: 603-10.
4. MANN JD, JOHNS TR, CAMPA JF, MULLER WH. Long-term prednisone followed by thymectomy in myasthenia gravis. Ann NY Acad Sci 1976: 274: 608-22.
5. JENKINS RB. Treatment of myasthenia gravis with prednisone. Lancet 1972: i: 765-7.
6. PASCUZZI RM, COSLETT HB, JOHNS TR. Long-term corticosteroid treatment of myasthenia gravis: report of 116 patients. Ann Neurol 1984: 15: 291-8.
7. SGHIRLANZONI A, PELUCHETTI C, MANTEGAZZA R, FIACCHINO F, CORNELIO F. Myasthenia gravis: prolonged treatment with steroids. Neurology 1984: 34: 170-4.
8. EVOLI A, BATOCCHI AP, PALMISANI MT, MONACO ML, TONALI P. Long-term results of corticosteroid therapy in patients with myasthenia gravis. Eur Neurol 1992: 32: 37-43.
9. PINELLI P, TONALI P, SCOPPETTA C. Long-term treatment of myasthenia gravis with alternate-day prednisone. Eur Neurol 1974: 12: 129-41.
10. MATELL G, BAERENDTZ S, HULTING J, MALMLUND HO. Effects on myasthenia of twin shock doses of methyl prednisolone (TSDMP). 1982: 5th Int Congr Neuromusc Diseases.
11. ARSURA E, BRUNNER NG, NAMBA T, GROB D. High-dose intravenous methylprednisolone in myasthenia gravis. Arch Neurol 1985: 42: 1149-53.
12. OSTERHUIS HJGH. MG. A review. Clin Neurol Neurosurg 1981: 83: 105-35.
13. LEFVERT AK. Idiotypes and antiidiotypes of human autoantibodies to the acetylcholine receptor. Monogr Allergy 1987: 22: 57-70.
14. WARMOLTS JR, ENGEL WK. Benefit from alternate-day prednisone in myasthenia gravis. N Engl J Med 1972: 286: 17-20.
15. MILLER RG, MILNER-BROWN HS, MIRKA A. Prednisone-induced worsening of neuromuscular function in myasthenia gravis. Neurology 1986: 36: 729-32.
16. OLSSON R, LINDBERG C, ANDERSEN O. Centrolobular liver-cell necrosis, myocardial infarction and hyperamylasaemia after high dose corticosteroids. BMJ 1994: 308: 454.
17. LYONS PR, NEWMAN PK, SAUNDERS M. Methylprednisolone therapy in multiple sclerosis: a profile of adverse effects. J Neurol Neurosurg Psychiatry 1988: 51: 285-7.
18. PANEGYRES PK, SQUIER M, MILLS KR, NEWSOM-DAVIS J. Acute myopathy associated with large parental dose of corticosteroid in myasthenia gravis. J Neurol Neurosurg Psychiatry 1993: 56: 702-4.
19. NEEDS CJ, SMITH M, BOUTAGY J et al. Comparison of Methylprednisolone (1 g IV) with Prednisolone (1 g orally) in rheumatoid arthritis: a pharmacokinetic and clinical study. J Rheumatol 1988: 15: 224-8.
20. MILLIGAN NM, NEWCOMBE R, COMPSTON DAS. A double-blind controlled trial of high-dose intravenous methyl-prednisolone in patients with multiple sclerosis. I. Clinical effects. J Neurol Neurosurg Psychiatry 1987: 50: 511-6.
21. WEUSTEN BLAM, JACOBS JWG, BULSMA JWJ. Corticosteroid pulse therapy in active rheumatoid arthritis. Semin Arthritis Rheum 1993: 23: 183-92.
22. ÅHLBERG R, PIRSKANEN R, MATELL G et al. Treatment of myasthenia gravis with anti-CD4 antibody: Improvement correlates to changes in T-cell reactivity. Neurology 1994: 44: 1732-7.
23. GROB D, SIMPSON D, MITSUMOTO H et al. Treatment of myasthenia gravis by immunoadsorption of plasma. Neurology 1995: 45: 338-44.
24. COSI V, LOMBARDI M, PICCOLO G, EBRETTA A. Treatment of myasthenia gravis with high-dose intravenous immunoglobulin. Acta Neurol Scand 1991: 84: 81-4.
25. TINDALL RSA, PHILLIPS JT, ROLLINS JA, WELLS L, HALL K. A clinical therapeutic trial of cyclosporine in myasthenia gravis. Ann NY Acad Sci 1993: 681: 539-51.